Orion
Stock
Stock
ISIN: FI0009014377
Ticker: ORNBV
FI0009014377
ORNBV
Price
Price
CHART BY
Historical dividends and forecast
Orion has so far distributed $1.751 in 2024. The next dividend will be paid on 03.04.2025
$1.706
CHART BY
Frequently asked questions
What is Orion's market capitalization?
The market capitalization of Orion is $6.27B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Orion's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Orion is 18.11. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Orion?
Orion's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.464. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Orion's stock?
Currently, 7 analysts cover Orion's stock, with a consensus target price of $52.17. Analyst ratings provide insights into the stock's expected performance.
What is Orion's revenue over the trailing twelve months?
Over the trailing twelve months, Orion reported a revenue of $1.49B.
What is the EBITDA for Orion?
Orion's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $444.24M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Orion?
Orion has a free cash flow of $201.36M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Orion have, and what sector and industry does it belong to?
Orion employs approximately 3,632 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of Orion's shares?
The free float of Orion is 103.84M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $6.27B
- EPS (TTM)
- $2.464
- Free Float
- 103.84M
- P/E ratio (TTM)
- 18.11
- Revenue (TTM)
- $1.49B
- EBITDA (TTM)
- $444.24M
- Free Cashflow (TTM)
- $201.36M
Pricing
- 1D span
- $43.16$44.66
- 52W span
- $33.91$55.85
Analyst Ratings
The price target is $52.17 and the stock is covered by 7 analysts.
Buy
5
Hold
1
Sell
1
Information
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland.
- Employees
- 3,632
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- FI0009014377
- Primary Ticker
- ORNBV